BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/3/2014 10:06:00 AM | Browse: 740 | Download: 705
Publication Name World Journal of Clinical Urology
Manuscript ID 7190
Country New Zealand
Received
2013-11-08 19:44
Peer-Review Started
2013-11-09 16:05
To Make the First Decision
2013-12-02 11:41
Return for Revision
2013-12-03 20:47
Revised
2013-12-19 06:44
Second Decision
2014-02-18 12:03
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-02-18 12:34
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-03-18 12:32
Publish the Manuscript Online
2014-03-25 11:20
ISSN 2219-2816 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Urology & Nephrology
Manuscript Type Minireviews
Article Title Role of β-microseminoprotein from prostate cancer initiation to recurrence: A mini-review
Manuscript Source Invited Manuscript
All Author List Nishi Karunasinghe, Karen Bishop, Pamela Murray, Yuanye Xu, Megan Goudie, Lance Ng, Shuotun Zhu, Dug Yeo Han, Lynnette R Ferguson, Jonathan Masters, Benji Benjamin and Michael Holmes
Funding Agency and Grant Number
Corresponding Author Nishi Karunasinghe, PhD, Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. n.karunasinghe@auckland.ac.nz
Key Words β-microseminoprotein; Anticancer properties; Immune modulation; Splice variants; Promoter single nucleotide polymorphism rs10993994; Biochemical recurrence
Core Tip Potential exists to use the ratio of MSMB full-length and short splice variants as a predictor of prostate cancer recurrence particularly after radiation therapy or surgical procedure or both. Control of the level of full-length splice variant in proportion to the short isoform could also carry a therapeutic use in controlling biochemical recurrence of the disease.
Publish Date 2014-03-25 11:20
Citation Karunasinghe N, Bishop K, Murray P, Xu Y, Goudie M, Ng L, Zhu S, Han DY, Ferguson LR, Masters J, Benjamin B, Holmes M. Role of β-microseminoprotein from prostate cancer initiation to recurrence: A mini-review. World J Clin Urol 2014; 3(1): 20-30
URL http://www.wjgnet.com/2219-2816/full/v3/i1/20.htm
DOI http://dx.doi.org/10.5410/wjcu.v3.i1.20
Full Article (PDF) wjcu-3-20.pdf
Full Article (Word) wjcu-3-20.doc
Manuscript File 7190-Review.doc
Answering Reviewers 7190-Answering reviewers.pdf
Copyright License Agreement 7190-Copyright assignment.pdf
Institutional Review Board Approval Form or Document Ethics_Committee_20131107111713.pdf
Peer-review Report 7190-Peer review(s).pdf
Scientific Editor Work List 7190-Scientific editor work list.doc